[Federal Register Volume 77, Number 24 (Monday, February 6, 2012)]
[Notices]
[Page 5849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2568]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 23, 2011, and published in the Federal 
Register on July 5, 2011, 76 FR 39127, Johnson Matthey Pharmaceutical 
Materials, Inc., Pharmaceuticals Service, 25 Patton Road, Devens, 
Massachusetts 01434, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Remifentanil (9739), the basic class of controlled substance in 
schedule II.
    The company plans to utilize this facility to manufacture small 
quantities of the listed controlled substance in bulk and to conduct 
analytical testing in support of the company's primary manufacturing 
facility in West Deptford, New Jersey. The controlled substances 
manufactured in bulk at this facility will be distributed to the 
company's customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Pharmaceutical Materials, Inc. to manufacture the 
listed basic class of controlled substance is consistent with the 
public interest at this time. DEA has investigated Johnson Matthey 
Pharmaceutical Materials, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, 
the above named company is granted registration as a bulk manufacturer 
of the basic class of controlled substance listed.

    Dated: January 27, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-2568 Filed 2-3-12; 8:45 am]
BILLING CODE 4410-09-P